Ajanta Pharma received US FDA approval and has launched Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma USA Inc. It is a bioequivalent generic version of Kapvay1 Tablets and company has launched the product in 0.1mg dosage. Clonidine Hydrochloride Extended Release Tablets is part of its portfolio of products that Ajanta has developed for the US market
Company Profile : Ajanta Pharma Ltd
Leave a Reply